US EditionTrump executive order backs change to Medicare negotiation pushed by drug industry
- President Donald Trump signed an executive order aimed at reducing healthcare costs by enhancing the Medicare negotiating system and lowering drug prices, including insulin for low-income individuals.
- The executive order seeks to match Medicare payments to the prices hospitals pay for prescription drugs, potentially reducing prices by as much as 60%.
- One provision revives a program to provide insulin for low-income patients at very low costs, previously ended by the Biden administration.
- The administration's goal is 22% savings in the Medicare program's first year, responding to rising prescription drug prices that increased over 15% between January 2022 and January 2023.
89 Articles
89 Articles
Drug Pricing Executive Order Boosts Pharmaceutical Industry’s Goals
On Tuesday, President Trump issued an executive order on prescription drug pricing that supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA) Medicare negotiation program, putting Medicare and beneficiary savings at risk. Since the IRA’s passage, drugmakers have been seeking ways to dilute or sidestep the negotiations, including by bolstering exemptions for certain medications. Since the IRA’s passage, drugmakers have …
Trump signs executive action to lower drug prices
President Trump signed an executive action Tuesday intended to lower prescription drug prices for Americans.A White House official, speaking on condition of anonymity, told reporters ahead of the signing that the move would include “delivering lower prices to seniors” and improve the Medicare drug price negotiation program, which was created by the Inflation Reduction Act that passed in 2022.“We are confident we will eclipse the savings the Bide…
Trump’s Executive Order on Prescription Drug Costs Delivers a Win for Pharma Companies
The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain drugs can be selected for negotiation. The post Trump’s Executive Order on Prescription Drug Costs Delivers a Win for Pharma Companies appeared first on MedCity News.
Trump Gives Big Pharma a Gift, Undermines Seniors
President Trump has signed a sweeping executive order that dilutes Medicare’s ability to negotiate prescription drug prices. Though the White House touts it as a measure to reduce healthcare costs, closer analysis reveals that the real beneficiaries are pharmaceutical companies—not seniors who rely on Medicare for prescription drug coverage. This move significantly erodes key elements of the Inflation Reduction Act (IRA), a landmark achievement …
'Just caved — again': Watchdogs warn Trump is backing down from major promise
U.S. President Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad category of prescription drugs, handing the deep-pocketed pharmaceutical industry a major win as it lobbies aggressively against efforts to rein in its pricing power.Trump's order, t...
Coverage Details
Bias Distribution
- 57% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
